source
- SonoThera secures $125 million to advance ultrasound-based gene therapy for Duchenne and polycystic kidney diseaseSonoThera announced it has raised $125 million in financing to move its ultrasound-based non-viral gene therapy platform toward clinical testing. The funding will support the company’s two lead pr…
- Sanofi halts rare disease trial as Parabilis launches record biotech IPO amid European pricing debateSanofi announced it is stopping a Phase 3 trial of its experimental drug riliprubart in a rare autoimmune disease after an interim analysis showed the treatment did not work. The pause adds to rec…